| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.057 | 0.8 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | Salubrinal | GDSC1000 | pan-cancer | AAC | -0.016 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.016 | 0.8 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.053 | 0.8 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |